Literature DB >> 20109888

Affordable medicines facility for malaria: reasonable or rash?

Mohga Kamal-Yanni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109888     DOI: 10.1016/S0140-6736(10)60048-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Retail sector distribution chains for malaria treatment in the developing world: a review of the literature.

Authors:  Edith Patouillard; Kara G Hanson; Catherine A Goodman
Journal:  Malar J       Date:  2010-02-11       Impact factor: 2.979

Review 2.  Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review.

Authors:  Cristina Lussiana
Journal:  Health Policy Plan       Date:  2015-04-09       Impact factor: 3.344

3.  Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania.

Authors:  Jessica L Cohen; Prashant Yadav; Corrina Moucheraud; Sarah Alphs; Peter S Larson; Jean Arkedis; Julius Massaga; Oliver Sabot
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

4.  Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies.

Authors:  Melissa A Briggs; Admirabilis Kalolella; Katia Bruxvoort; Ryan Wiegand; Gerard Lopez; Charles Festo; Pierre Lyaruu; Mitya Kenani; Salim Abdulla; Catherine Goodman; S Patrick Kachur
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

5.  Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria.

Authors:  Rebecca Thomson; Charles Festo; Boniface Johanes; Admirabilis Kalolella; Katia Bruxvoort; Happy Nchimbi; Sarah Tougher; Matthew Cairns; Mark Taylor; Immo Kleinschmidt; Yazoume Ye; Andrea Mann; Ruilin Ren; Barbara Willey; Fred Arnold; Kara Hanson; S Patrick Kachur; Catherine Goodman
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.